3 hours Leerink Partnrs Has Pessimistic View of JAZZ FY2024 EarningsMarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Research analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Tuesday, October 15th. Leerink…
Earnings · Nasdaq 100 · Pharmaceuticals · Science
X